Morgan Stanley’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-785,270
| Closed | -$89K | – | 6843 |
|
|
2018
Q4 | $89K | Sell |
785,270
-70,252
| -8% | -$46.1K | ﹤0.01% | 5595 |
|
|
2018
Q3 | $1.45M | Buy |
855,522
+78,062
| +10% | +$140K | ﹤0.01% | 4242 |
|
|
2018
Q2 | $1.35M | Sell |
777,460
-959,709
| -55% | -$1.66M | ﹤0.01% | 4413 |
|
|
2018
Q1 | $3.18M | Buy |
1,737,169
+353,123
| +26% | +$746K | ﹤0.01% | 3541 |
|
|
2017
Q4 | $3.09M | Sell |
1,384,046
-609,900
| -31% | -$1.52M | ﹤0.01% | 3618 |
|
|
2017
Q3 | $5.78M | Buy |
1,993,946
+132,961
| +7% | +$454K | ﹤0.01% | 2807 |
|
|
2017
Q2 | $8.28M | Buy |
1,860,985
+1,046,319
| +128% | +$4.31M | ﹤0.01% | 2362 |
|
|
2017
Q1 | $3.8M | Sell |
814,666
-397,574
| -33% | -$2.31M | ﹤0.01% | 3157 |
|
|
2016
Q4 | $7.38M | Sell |
1,212,240
-34,307
| -3% | -$179K | ﹤0.01% | 2585 |
|
|
2016
Q3 | $6.87M | Buy |
1,246,547
+733,123
| +143% | +$3.43M | ﹤0.01% | 2356 |
|
|
2016
Q2 | $1.95M | Buy |
513,424
+170,751
| +50% | +$579K | ﹤0.01% | 3444 |
|
|
2016
Q1 | $946K | Sell |
342,673
-80,847
| -19% | -$293K | ﹤0.01% | 3986 |
|
|
2015
Q4 | $2.4M | Buy |
423,520
+27,037
| +7% | +$165K | ﹤0.01% | 3332 |
|
|
2015
Q3 | $2.1M | Sell |
396,483
-65,666
| -14% | -$508K | ﹤0.01% | 3465 |
|
|
2015
Q2 | $3.84M | Sell |
462,149
-370,347
| -44% | -$1.8M | ﹤0.01% | 3030 |
|
|
2015
Q1 | $3.85M | Sell |
832,496
-248,286
| -23% | -$807K | ﹤0.01% | 3004 |
|
|
2014
Q4 | $3.3M | Buy |
1,080,782
+199,024
| +23% | +$589K | ﹤0.01% | 3110 |
|
|
2014
Q3 | $2.46M | Sell |
881,758
-79,536
| -8% | -$289K | ﹤0.01% | 3262 |
|
|
2014
Q2 | $3.91M | Buy |
961,294
+130,494
| +16% | +$554K | ﹤0.01% | 2890 |
|
|
2014
Q1 | $4.41M | Buy |
830,800
+61,881
| +8% | +$347K | ﹤0.01% | 2693 |
|
|
2013
Q4 | $4.27M | Sell |
768,919
-121,189
| -14% | -$523K | ﹤0.01% | 2719 |
|
|
2013
Q3 | $4.01M | Sell |
890,108
-28,758
| -3% | -$129K | ﹤0.01% | 2642 |
|
|
2013
Q2 | $3.91M | Buy |
+918,866
| New | +$4.62M | ﹤0.01% | 2562 |
|
Other funds holding SGYP
Morgan Stanley's SGYP Position: Q1 2019 in Review
Morgan Stanley sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 785,270 shares — an estimated $89K sold.
Morgan Stanley first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $8.28M in Q2 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Morgan Stanley reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Morgan Stanley sold 785,270 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $89K.
- Morgan Stanley first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Morgan Stanley's Synergy Pharmaceuticals, Inc Common Stock position peaked at $8.28M in Q2 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.